Daily Judi: Tuesday, November 8, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
A new study published in the Journal of the American College of Cardiology indicated a higher myocarditis risk after a second dose of Moderna's COVID-19 vaccine compared with the Pfizer-BioNTech COVID-19 vaccine. (Fierce Pharma)
The results of a trial of an experimental weight-loss drug developed by Amgen showed positive results. The new drug helped obese people lose up to 15% of body weight. (BioPharma Dive)
Researchers at MIT are designing ingestible medical devices that can be safely broken down and removed from the body without surgery. (MIT News)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”
–Tim, Trial Delivery
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.